Resmed (RMD) Equity Ratio (2010 - 2026)

Resmed has reported Equity Ratio for 17 years, with the latest figure at 0.74 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio rose 0.83% year-over-year to 0.74; the trailing twelve-month figure through Mar 2026 stood at 0.74 (up 0.83% YoY), and the FY2025 full-year result was 0.73, up 3.15% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.74, down from 0.74 in the prior quarter.
• The five-year high for Equity Ratio was 0.74 in Q4 2025, with the low at 0.56 in Q4 2022.
• Historically, Equity Ratio has averaged 0.68 across 5 years, with a median of 0.68 in 2024.
• Annual changes were most pronounced in 2022 — Equity Ratio retreated 15.73% — and 2024, when it grew 16.0%.
• Resmed's Equity Ratio stood at 0.56 in 2022, then climbed by 15.92% to 0.65 in 2023, then gained by 13.33% to 0.74 in 2024, then grew by 1.05% to 0.74 in 2025, then decreased by 0.58% to 0.74 in 2026.
• The last three Equity Ratio figures came in at 0.74 (Q1 2026), 0.74 (Q4 2025), and 0.74 (Q3 2025), per Business Quant data.